


Ask a doctor about a prescription for HIRUDOID FORTE 4.45 mg/g GEL
PACKAGE LEAFLET: INFORMATION FOR THE USER
HirudoidForte 4.45 mg/g gel
Sodium chondroitin sulfate
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
Contents of the package leaflet:
Hirudoid Forte is a medication that contains sodium chondroitin sulfate as the active ingredient and has properties that favor blood flow.
This medication is indicated for:
local symptomatic relief of superficial venous disorders such as heaviness and tightness in legs with varicose veins in adults
local symptomatic relief of superficial hematomas caused by bruises in adults and children over 1 year of age.
You should consult a doctor if your condition worsens or does not improve after 5 days.
Do not use Hirudoid Forte
Warnings and precautions
Consult your doctor or pharmacist before starting to use Hirudoid Forte.
In case of venous problems caused by blood clots (such as thromboembolism, obstruction of a blood vessel that hinders blood flow), it is recommended to apply the product gently and without massage.
Using Hirudoid Forte with other medications
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
It is not recommended to apply other topical preparations to the same area without consulting your doctor.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should not use Hirudoid during pregnancy or breastfeeding unless your doctor advises you to do so.
Driving and using machines
No effects on the ability to drive vehicles or use machinery have been reported.
Hirudoid Forte contains propylene glycol
This medication contains 5 mg of propylene glycol per gram of gel. Propylene glycol may cause skin irritation.
This medication contains propylene glycol; do not use on open wounds or large areas of damaged skin (such as burns) without consulting your doctor or pharmacist first.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
This medication is for topical use (exclusively on the skin). The recommended dose is:
Superficial venous disorders
Adults:apply a thin layer of gel or ointment to the affected area 2 to 3 times a day, distributing it with a gentle massage to facilitate penetration.
Wash your hands after each application to avoid unintentional contact with eyes and mucous membranes.
The average treatment duration is usually between 1 and 2 weeks. If symptoms worsen or persist after 5 days of treatment, you should consult a doctor.
Children under 18 years:do not use without medical supervision.
Hematomas:
Adults and children over 1 year:apply a thin layer of gel or ointment to the affected area 2 to 3 times a day, distributing it with a gentle massage to facilitate penetration.
Wash your hands after each application to avoid unintentional contact with eyes and mucous membranes. The average treatment duration for hematomas is usually less than 10 days. If symptoms worsen or persist after 5 days of treatment, you should consult a doctor. Children under 1 year:do not use without medical supervision.
If you use more Hirudoid Forte than you should
If you have used more Hirudoid Forte than you should or in case of accidental ingestion, consult the Toxicology Information Service. Telephone 91 562 04 20, indicating the medication and the amount ingested.
Accidental ingestion of large amounts of Hirudoid Forte gel due to its content of isopropyl alcohol may cause symptoms of acute alcohol intoxication.
In case of possible alcohol intoxication, special therapeutic measures should be initiated immediately.
If you forget to use Hirudoid Forte
Do not apply a double dose to make up for forgotten doses.
You should continue treatment as usual without taking any particular action.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Hirudoid can cause side effects, although not everyone will experience them.
It has been observed that very rarely (affects less than 1 in 10,000 patients), allergic reactions may occur at the application site, which can manifest as itching and irritation, and which disappear when treatment is discontinued.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the national reporting system included in the Spanish Medicines and Healthcare Products Agency (AEMPS) Website: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
You should discard the tube 12 months after the first opening. Write the opening date in the space provided on the box.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Hirudoid Forte composition
Appearance of the product and package contents
Hirudoid Forte is available in lacquered aluminum tubes containing 30, 60, and 100 grams of gel.
Marketing authorization holder
Laboratory STADA S.L. Frederic Mompou, 5
08960 Sant Just Desvern (Spain) [email protected]
Manufacturer
Mobilat Produktions GmbH Luitpoldstrasse 1
85276 Pfaffenhofen Germany
or
STADA Arzneimittel AG Stadastrasse 2-18
61118 - Bad Vilbel
Germany
Date of the last revision of this package leaflet: September 2021
"Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/"
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for HIRUDOID FORTE 4.45 mg/g GEL – subject to medical assessment and local rules.